Anamorelin improves appetite and body mass in non-small cell lung cancer with cancer anorexia-cachexia

New drug anamorelin shows improvement in appetite and body mass in non-small cell lung cancer with cancer anorexia-cachexia

Impact of biomarker-integrated approaches of targeted therapy for lung cancer elimination

Proactive P4 medicine making blood a window into health and disease

microRNA replacement in malignant pleural mesothelioma

Investigating anticarcinogenic compounds as an alternative to chemo

Comment: Advances in lung cancer presented at ASCO 2014

Ramucirumab plus docetaxel extends survival in advanced NSCLC

Second-line treatment with ramucirumab plus docetaxel extends survival in advanced NSCLC

Intratumour heterogeneity in renal and lung cancer

Role of AORTIC in dealing with rising cancer rates in Africa

Promising advances in the treatment of lung cancer using MK-3475 as an immune checkpoint inhibitor